Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
23/03 | 2,560 USD
-5,19% |
-5,19% |
|
Cabaletta Bio Inc |
23/03 | 2,820 USD
-4,08% |
-4,08% |
|
Calithera Biosciences Inc |
19/03 | 0,000 USD
0,00% |
0,00% |
Cambridge Cognition Holdings plc |
23/03 | 36,000 GBX
-1,37% |
-1,37% |
|
Can-Fite Biopharma Ltd |
23/03 | 3,240 USD
+2,21% |
+2,21% |
|
Capricor Therapeutics Inc |
23/03 | 30,100 USD
+3,44% |
+3,44% |
Carbios |
23/03 | 7,975 EUR
+4,04% |
+4,04% |
Cardiol Therapeutics Inc - Class A |
23/03 | 1,340 CAD
+3,88% |
+3,88% |
|
Caredx Inc |
23/03 | 17,560 USD
+2,39% |
+2,39% |
|
Carisma Therapeutics, Inc. |
23/03 | 0,038 USD
+4,31% |
+4,31% |
|
Carmat |
26/09 | 0,099 EUR
0,00% |
0,00% |
|
CASI Pharmaceuticals Inc |
20/03 | 0,150 USD
0,00% |
0,00% |
|
Cassava Sciences Inc |
23/03 | 1,880 USD
+3,58% |
+3,58% |
|
Castle Biosciences Inc |
23/03 | 25,750 USD
+3,00% |
+3,00% |
|
Catalyst Pharmaceuticals Inc |
23/03 | 23,320 USD
+2,33% |
+2,33% |
|
Cel-Sci Corp. |
23/03 | 3,480 USD
+1,16% |
+1,16% |
|
Celldex Therapeutics Inc. |
23/03 | 31,800 USD
+2,91% |
+2,91% |
|
Cellectar Biosciences Inc |
23/03 | 3,120 USD
-3,70% |
-3,70% |
|
Cellectis |
23/03 | 3,420 USD
+2,40% |
+2,40% |
|
Cellectis |
24/03 | 2,870 EUR
-4,81% |
-4,81% |
Celyad Oncology |
24/03 | 0,320 EUR
-2,74% |
-2,74% |
|
Cerus Corp. |
23/03 | 1,820 USD
+5,81% |
+5,81% |
|
Champions Oncology Inc |
23/03 | 5,960 USD
+1,71% |
+1,71% |
|
Charlottes Web Holdings Inc |
23/03 | 0,960 CAD
-3,03% |
-3,03% |
|
China Pharma Holdings Inc. |
23/03 | 0,627 USD
+16,11% |
+16,11% |
|
China SXT Pharmaceuticals Inc |
23/03 | 1,470 USD
+5,00% |
+5,00% |
|
Cipher Pharmaceuticals Inc |
23/03 | 16,560 CAD
-0,06% |
-0,06% |
|
Citius Pharmaceuticals Inc |
23/03 | 0,751 USD
-2,52% |
-2,52% |
|
Clean Air Metals Inc |
23/03 | 0,065 CAD
+8,33% |
+8,33% |
|
ClearPoint Neuro Inc |
23/03 | 9,510 USD
+5,32% |
+5,32% |
|
Clearside Biomedical Inc |
20/03 | 0,565 USD
-5,85% |
-5,85% |
|
Cns Pharmaceuticals Inc |
23/03 | 2,515 USD
+9,83% |
+9,83% |
|
Co-Diagnostics Inc |
23/03 | 2,280 USD
-11,97% |
-11,97% |
|
Cocrystal Pharma Inc |
23/03 | 1,080 USD
+4,85% |
+4,85% |
|
Cogent Biosciences Inc |
20/03 | 33,380 USD
-3,55% |
-3,55% |
|
Coherus Biosciences Inc |
23/03 | 1,640 USD
+7,89% |
+7,89% |
|
Collegium Pharmaceutical Inc |
23/03 | 34,735 USD
-1,99% |
-1,99% |
|
CollPlant Biotechnologies Ltd |
23/03 | 0,607 USD
-1,30% |
-1,30% |
Coloplast |
23/03 | 56,660 EUR
+0,43% |
+0,43% |
|
Compass Pathways Plc |
23/03 | 5,340 USD
-1,29% |
-1,29% |
|
Compass Therapeutics Inc |
23/03 | 5,040 USD
-2,14% |
-2,14% |
|
Compugen Ltd. |
23/03 | 2,090 USD
0,00% |
0,00% |
|
Conmed Corp. |
23/03 | 36,630 USD
+1,92% |
+1,92% |
|
Convatec Group |
23/03 | 217,600 GBX
-0,73% |
-0,73% |
|
Cooper Companies, Inc. |
23/03 | 70,240 USD
+0,40% |
+0,40% |
|
Corbus Pharmaceuticals Holdings Inc |
23/03 | 8,430 USD
-1,98% |
-1,98% |
|
Corcept Therapeutics Inc |
23/03 | 33,630 USD
-2,92% |
-2,92% |
|
CorMedix Inc |
20/03 | 6,250 USD
-0,79% |
-0,79% |
|
Corvus Pharmaceuticals Inc |
23/03 | 13,750 USD
+3,15% |
+3,15% |
|
Covalon Technologies Ltd. |
23/03 | 1,750 CAD
+2,34% |
+2,34% |
|
Creo Medical Group Plc |
23/03 | 12,125 GBX
+3,19% |
+3,19% |
|
Crescita Therapeutics Inc |
23/03 | 0,740 CAD
0,00% |
0,00% |
|
Crinetics Pharmaceuticals Inc |
23/03 | 34,710 USD
-2,42% |
-2,42% |
|
CRISPR Therapeutics AG |
23/03 | 46,880 USD
+1,38% |
+1,38% |
|
Cronos Group Inc |
23/03 | 2,520 USD
+5,44% |
+5,44% |
|
Crossject |
24/03 | 2,040 EUR
-4,00% |
-4,00% |
|
Cryo-Cell International, Inc. |
23/03 | 3,120 USD
0,00% |
0,00% |
|
Cue Biopharma Inc |
23/03 | 0,266 USD
+0,15% |
+0,15% |
|
Cumberland Pharmaceuticals Inc. |
23/03 | 3,050 USD
+7,77% |
+7,77% |
|
CureVac N.V. |
5/01 | 3,892 EUR
+0,36% |
+0,36% |
|
Curis Inc |
23/03 | 0,740 USD
-4,07% |
-4,07% |
|
Currenc Group Inc. |
23/03 | 2,430 USD
-8,30% |
-8,30% |
|
Cyanotech Corp. |
23/03 | 0,350 USD
+12,54% |
+12,54% |
|
Cyclerion Therapeutics Inc |
23/03 | 1,590 USD
0,00% |
0,00% |
|
Cytokinetics Inc |
23/03 | 60,950 USD
-1,22% |
-1,22% |
|
CytomX Therapeutics Inc |
23/03 | 4,460 USD
+0,22% |
+0,22% |
|
Cytosorbents Corp |
23/03 | 0,674 USD
+2,06% |
+2,06% |
Nieuws over “Gezondheidstechnologie”
